Publicaciones en las que colabora con Lluís Masana Marín (2)

2023

  1. Implications of ACC/AHA Versus ESC/EAS LDL-C Recommendations for Residual Risk Reduction in ASCVD: A Simulation Study From DA VINCI

    Cardiovascular Drugs and Therapy, Vol. 37, Núm. 5, pp. 941-953

2017

  1. Cost-effectiveness of Evolocumab in Patients With High Cardiovascular Risk in Spain

    Clinical Therapeutics, Vol. 39, Núm. 4, pp. 771-786.e3